Related references
Note: Only part of the references are listed.Topical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasia (TOPIC-3): A Nonrandomized Multicenter Study
Natasja Hendriks et al.
JOURNAL OF IMMUNOTHERAPY (2022)
The use of host cell DNA methylation analysis in the detection and management of women with advanced cervical intraepithelial neoplasia: a review
W. W. Kremer et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2021)
The role of HPV-induced epigenetic changes in cervical carcinogenesis (Review)
Martha Laysla Ramos Da Silva et al.
BIOMEDICAL REPORTS (2021)
cGAS-STING signaling in cancer immunity and immunotherapy
Huashan Du et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Infiltrating T-cell markers in cervical carcinogenesis: a systematic review and meta-analysis
Tamara R. Litwin et al.
BRITISH JOURNAL OF CANCER (2021)
Microbiome and Cervical Cancer
Cristina Paula Castanheira et al.
PATHOBIOLOGY (2021)
The immune landscape during the tumorigenesis of cervical cancer
Yiying Wang et al.
CANCER MEDICINE (2021)
The vaginal microbiota and innate immunity after local excisional treatment for cervical intraepithelial neoplasia
Anita Mitra et al.
GENOME MEDICINE (2021)
Turning tumors from cold to inflamed to improve immunotherapy response
C. L. Gerard et al.
CANCER TREATMENT REVIEWS (2021)
Age-related distribution of uncommon HPV genotypes in cervical intraepithelial neoplasia grade 3
Luca Giannella et al.
GYNECOLOGIC ONCOLOGY (2021)
Primary vulvar squamous cell carcinomas with high T cell infiltration and active immune signaling are potential candidates for neoadjuvant PD-1/PD-L1 immunotherapy
Kim E. Kortekaas et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Comparison of Conservative Treatment of Cervical Intraepithelial Lesions with Imiquimod with Standard Excisional Technique Using LLETZ: A Randomized Controlled Trial
Andrej Cokan et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Bacterial vaginosis and health-associated bacteria modulate the immunometabolic landscape in 3D model of human cervix
Pawel Laniewski et al.
NPJ BIOFILMS AND MICROBIOMES (2021)
Topical Imiquimod for the Treatment of High-Grade Squamous Intraepithelial Lesions of the Cervix A Randomized Controlled Trial
Bruno O. Fonseca et al.
OBSTETRICS AND GYNECOLOGY (2021)
The Immune Microenvironment in Human Papilloma Virus-Induced Cervical Lesions-Evidence for Estrogen as an Immunomodulator
R. S. Jayshree
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Cervical intraepithelial neoplasia and the risk of spontaneous preterm birth: A Dutch population-based cohort study with 45,259 pregnancy outcomes
Diede L. Loopik et al.
PLOS MEDICINE (2021)
IL-35 Regulates the Function of Immune Cells in Tumor Microenvironment
Kewei Liu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Multiplex Immunofluorescence and Multispectral Imaging: Forming the Basis of a Clinical Test Platform for Immuno-Oncology
Clifford C. Hoyt
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
The Natural History of Cervical Intraepithelial Neoplasia Grades 1, 2, and 3: A Systematic Review and Meta-analysis
Diede L. Loopik et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2021)
The microbiome and gynaecological cancer development, prevention and therapy
Pawel Laniewski et al.
NATURE REVIEWS UROLOGY (2020)
Treg Heterogeneity, Function, and Homeostasis
Daniil Shevyrev et al.
FRONTIERS IN IMMUNOLOGY (2020)
The Interplay Between Reproductive Tract Microbiota and Immunological System in Human Reproduction
Salwan Al-Nasiry et al.
FRONTIERS IN IMMUNOLOGY (2020)
Pre-existing inflammatory immune microenvironment predicts the clinical response of vulvar high-grade squamous intraepithelial lesions to therapeutic HPV16 vaccination
Ziena Abdulrahman et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
A pre-existing coordinated inflammatory microenvironment is associated with complete response of vulvar high-grade squamous intraepithelial lesions to different forms of immunotherapy
Ziena Abdulrahman et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
The Association Between Vaginal Microbiota Dysbiosis, Bacterial Vaginosis, and Aerobic Vaginitis, and Adverse Pregnancy Outcomes of Women Living in Sub-Saharan Africa: A Systematic Review
Naomi C. A. Juliana et al.
FRONTIERS IN PUBLIC HEALTH (2020)
Topical therapies for the treatment of cervical intraepithelial neoplasia (CIN) 2-3: A narrative review
Nerlyne Desravines et al.
GYNECOLOGIC ONCOLOGY REPORTS (2020)
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Rebecca B. Perkins et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2020)
PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations
Yongshuai Jiang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Prognostic factors for spontaneous regression of high-risk human papillomavirus-positive cervical intra-epithelial neoplasia grade 2
Margot M. Koeneman et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)
The relation of the vaginal microbiota to early pregnancy development during in vitro fertilization treatment-A meta-analysis
M. Singer et al.
JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION (2019)
High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status
Kim E. Kortekaas et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Efficacy of commercially available biological agents for the topical treatment of cervical intraepithelial neoplasia: a systematic review
Alex Baleka Mutombo et al.
SYSTEMATIC REVIEWS (2019)
Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multicentre, randomised, phase II trial (RT3VIN)
C. N. Hurt et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2018)
Conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women under 30 years of age: A cohort study
Michelle A. L. Godfrey et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2018)
Safety and tolerance of cidofovir as a 2% gel for local application in high-grade cervical intraepithelial neoplasia: A phase 1 investigation
Michel Bossens et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2018)
Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis
Karoliina Tainio et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis
Karoliina Tainio et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Role of Lactobacilli and Lactoferrin in the Mucosal Cervicovaginal Defense
Piera Valenti et al.
FRONTIERS IN IMMUNOLOGY (2018)
Toll-like receptors: Important immune checkpoints in the regression of cervical intra-epithelial neoplasia 2
Gordana Halec et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
The immune microenvironment in vulvar (pre)cancer: review of literature and implications for immunotherapy
Ziena Abdulrahman et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2018)
Intratumoral HPV16-Specific T Cells Constitute a Type I-Oriented Tumor Microenvironment to Improve Survival in HPV16-Driven Oropharyngeal Cancer
Marij J. P. Welters et al.
CLINICAL CANCER RESEARCH (2018)
Outcomes of Conservative Management of High Grade Squamous Intraepithelial Lesions in Young Women
Marette H. Lee et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2018)
The twilight of immunity: emerging concepts in aging of the immune system
Janko Nikolich-Zugich
NATURE IMMUNOLOGY (2018)
A prediction model for spontaneous regression of cervical intraepithelial neoplasia grade 2, based on simple clinical parameters
Margot M. Koeneman et al.
HUMAN PATHOLOGY (2017)
Tumor-associated macrophages: from basic research to clinical application
Li Yang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota
B. Shannon et al.
MUCOSAL IMMUNOLOGY (2017)
Does the vaginal microbiota play a role in the development of cervical cancer?
Maria Kyrgiou et al.
TRANSLATIONAL RESEARCH (2017)
Clinical Significance of CD163+and CD68+Tumor-associated Macrophages in High-risk HPV-related Cervical Cancer
Xiao-Jing Chen et al.
JOURNAL OF CANCER (2017)
Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Maria Kyrgiou et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer
Nancy Santesso et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2016)
Innate immune mediators in cancer: between defense and resistance
Pedro Berraondo et al.
IMMUNOLOGICAL REVIEWS (2016)
Regression and Progression Predictors of CIN2 in Women Younger Than 25 Years
Diede L. Loopik et al.
Journal of Lower Genital Tract Disease (2016)
Vaccines for established cancer: overcoming the challenges posed by immune evasion
Sjoerd H. van der Burg et al.
NATURE REVIEWS CANCER (2016)
Is Age an Independent Predictor of High-Grade Histopathology in Women Referred for Colposcopy after Abnormal Cervical Cytology?
Chalita Kingnate et al.
Asian Pacific Journal of Cancer Prevention (2015)
Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: A review
C. J. de Witte et al.
GYNECOLOGIC ONCOLOGY (2015)
Cervicovaginal Bacteria Are a Major Modulator of Host Inflammatory Responses in the Female Genital Tract
Melis N. Anahtar et al.
IMMUNITY (2015)
Local immunosuppression induced by high viral load of human papillomavirus: characterization of cellular phenotypes producing interleukin-10 in cervical neoplastic lesions
Thiago Theodoro Martins Prata et al.
IMMUNOLOGY (2015)
Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
Cornelia L. Trimble et al.
LANCET (2015)
Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers
Louisa Mezache et al.
MODERN PATHOLOGY (2015)
Balancing the innate immune system in tumor development
Catharina Hagerling et al.
TRENDS IN CELL BIOLOGY (2015)
Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
Bin Shang et al.
SCIENTIFIC REPORTS (2015)
Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity
A. Mitra et al.
SCIENTIFIC REPORTS (2015)
Immunohistochemical Characterization and Morphometric Analysis of Macrophages in Rat Mammary Tumors
C. B. Ong et al.
VETERINARY PATHOLOGY (2015)
The ins and outs of MHC class II-mediated antigen processing and presentation
Paul A. Roche et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Factors Associated With the Persistence/Recurrence of CIN2/3 in Women Submitted to Loop Electrosurgical Excision Procedure in a Teaching Hospital in Northeastern Brazil
Marília Vieira de Mello Silva et al.
Journal of Lower Genital Tract Disease (2014)
Condom use in prevention of Human Papillomavirus infections and cervical neoplasia: systematic review of longitudinal studies
Janni Uyen Hoa Lam et al.
JOURNAL OF MEDICAL SCREENING (2014)
Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT3VIN): a multicentre, open-label, randomised, phase 2 trial
Amanda Tristram et al.
LANCET ONCOLOGY (2014)
Intramuscular Therapeutic Vaccination Targeting HPV16 Induces T Cell Responses That Localize in Mucosal Lesions
Leonel Maldonado et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Trial Watch Adoptive cell transfer for anticancer immunotherapy
Fernando Aranda et al.
ONCOIMMUNOLOGY (2014)
The Prevalence Of Cervical Regulatory T Cells in HPV-Related Cervical Intraepithelial Neoplasia (CIN) Correlates Inversely with Spontaneous Regression of CIN
Satoko Kojima et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2013)
Cervical surgery for cervical intraepithelial neoplasia and prolonged time to conception of a live birth: a case-control study
C. N. Spracklen et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2013)
Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up
K. E. Jensen et al.
BRITISH JOURNAL OF CANCER (2013)
Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia
Wen Yang et al.
IMMUNOLOGY (2013)
Tumor-infiltrating CD14-positive myeloid cells and CD8-positive T-cells prolong survival in patients with cervical carcinoma
P. J. de Vos van Steenwijk et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Treatment of vulvar intraepithelial neoplasia with topical 5% imiquimod cream
Claudia Westermann et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2013)
Efficacy of imiquimod 5% cream for persistent human papillomavirus in genital intraepithelial neoplasm
Fang-Ping Chen
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2013)
Prognostic Significance of Immunohistochemical Phenotypes in Patients Treated for High-Grade Cervical Intraepithelial Neoplasia
Massimo Origoni et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Immature, semi-mature, and fully mature dendritic cells: toward a DC-cancer cells interface that augments anticancer immunity
Aleksandra M. Dudek et al.
FRONTIERS IN IMMUNOLOGY (2013)
Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia
Deirdre R. Pachman et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions
Peggy J. de Vos van Steenwijk et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Treatment failure in patients with HPV 16-induced vulvar intraepithelial neoplasia: understanding different clinical responses to immunotherapy
Edith M. G. van Esch et al.
EXPERT REVIEW OF VACCINES (2012)
Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma
Qinghua Feng et al.
GYNECOLOGIC ONCOLOGY (2012)
Interaction of epithelial biomarkers, local immune response and condom use in cervical intraepithelial neoplasia 2-3 regression
Ane Cecilie Munk et al.
GYNECOLOGIC ONCOLOGY (2012)
Local cytokine profiles of patients with cervical intraepithelial and invasive neoplasia
Bethanea Crema Peghini et al.
HUMAN IMMUNOLOGY (2012)
Host Indoleamine 2,3-Dioxygenase: Contribution to Systemic Acquired Tumor Tolerance
Theodore S. Johnson et al.
IMMUNOLOGICAL INVESTIGATIONS (2012)
Treatment of Cervical Intraepithelial Neoplasia With Topical Imiquimod A Randomized Controlled Trial
Christoph Grimm et al.
OBSTETRICS AND GYNECOLOGY (2012)
Consistent Condom Use Increases the Regression Rate of Cervical Intraepithelial Neoplasia 2-3
Ane Cecilie Munk et al.
PLOS ONE (2012)
Topical imiquimod treatment for human papillomavirus infection in patients with and without cervical/vaginal intraepithelial neoplasia
Cheng-Tao Lin et al.
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2012)
The Biology and Life-Cycle of Human Papillomaviruses
John Doorbar et al.
VACCINE (2012)
Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature
Angiolo Gadducci et al.
GYNECOLOGICAL ENDOCRINOLOGY (2011)
Association between toll-like receptor expression and human papillomavirus type 16 persistence
Ibrahim I. Daud et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
The known unknowns of HPV natural history
Patti E. Gravitt
JOURNAL OF CLINICAL INVESTIGATION (2011)
Persistence of viral DNA in the epithelial basal layer suggests a model for papillomavirus latency following immune regression
Gareth Adam Maglennon et al.
VIROLOGY (2011)
European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition-Summary Document
M. Arbyn et al.
ANNALS OF ONCOLOGY (2010)
Tobacco smoking and regression of low-grade cervical abnormalities
Koji Matsumoto et al.
CANCER SCIENCE (2010)
Stromal issues in cervical cancer: a review of the role and function of basement membrane, stroma, immune response and angiogenesis in cervical cancer development
Shaira Sahebali et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2010)
The role of macrophages and mast cells in lymphangiogenesis and angiogenesis in cervical carcinogenesis
Dolores Utrera-Barillas et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2010)
The PD-1 pathway in tolerance and autoimmunity
Loise M. Francisco et al.
IMMUNOLOGICAL REVIEWS (2010)
Imiquimod-induced clearance of HPV is associated with normalization of immune cell counts in usual type vulvar intraepithelial neoplasia
Annelinde Terlou et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
A prospective study on the natural course of low-grade squamous intraepithelial lesions and the presence of HPV16 E2-, E6-and E7-specific T-cell responses
Yin Ling Woo et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Human Papillomavirus 16-Associated Cervical Intraepithelial Neoplasia in Humans Excludes CD8 T Cells from Dysplastic Epithelium
Cornelia L. Trimble et al.
JOURNAL OF IMMUNOLOGY (2010)
Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence
Susanne K. Kjaer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression
Irene Tveiteras Ovestad et al.
MODERN PATHOLOGY (2010)
Rate of and Risks for Regression of Cervical Intraepithelial Neoplasia 2 in Adolescents and Young Women
Anna-Barbara Moscicki et al.
OBSTETRICS AND GYNECOLOGY (2010)
Topical treatment of CIN 2+by cidofovir: Results of a phase II, double-blind, prospective, placebo-controlled study
C. Van Pachterbeke et al.
GYNECOLOGIC ONCOLOGY (2009)
Human immunodeficiency virus and human papilloma virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful
Sjoerd H. van der Burg et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia-Grade 2
Philip E. Castle et al.
OBSTETRICS AND GYNECOLOGY (2009)
Persistent human papillomavirus infection and cervical neoplasia: A systematic review and meta-analysis
Jill Koshiol et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Regulatory T cells in a spectrum of HPV-Induced cervical lesions: Cervicitis, cervical intraepithelial neoplasia and squamous cell carcinoma
Sreenivas Adurthi et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2008)
Characterising the local immune responses in cervical intraepithelial neoplasia: a cross-sectional and longitudinal analysis
Y. L. Woo et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2008)
Surgery followed by Persistence of High-Grade Squamous Intraepithelial Lesions Is Associated with the Induction of a Dysfunctional HPV16-Specific T-Cell Response
Peggy J. de Vos van Steenwijk et al.
CLINICAL CANCER RESEARCH (2008)
Induction of tumor-specific CD4+ and CD8+ T-Cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine
Marij J. P. Welters et al.
CLINICAL CANCER RESEARCH (2008)
Integration of human papillomavirus type-16 and type-18 is a very early event in cervical carcinogenesis
L. -W Huang et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Evolving immunosuppressive microenvironment during human cervical carcinogenesis
A. Kobayashi et al.
MUCOSAL IMMUNOLOGY (2008)
Natural History of Human Papillomavirus Infections, Cytologic and Histologic Abnormalities, and Cancer
Cosette Marie Wheeler
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA (2008)
Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia
F. Xavier Bosch et al.
VACCINE (2008)
High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells
G. Bottley et al.
ONCOGENE (2008)
Natural regulatory T cells and persistent viral infection
Shuo Li et al.
JOURNAL OF VIROLOGY (2008)
Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (UN 2/3)
Andreas M. Kaufmann et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Imiquimod:: mode of action
M. P. Schoen et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Lauren W. Collison et al.
NATURE (2007)
Human papillomavirus and cervical cancer
Mark Schiffman et al.
LANCET (2007)
European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology
M. Arbyn et al.
CYTOPATHOLOGY (2007)
Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression- : Clinicopathological correlation
Luciano S. Hammes et al.
GYNECOLOGIC ONCOLOGY (2007)
The natural history of cervical HPV infection: unresolved issues
Ciaran B. J. Woodman et al.
NATURE REVIEWS CANCER (2007)
HPV type-distribution in women with and without cervical neoplastic diseases
Gary Clifford et al.
VACCINE (2006)
Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix
Sylvain Monnier-Benoit et al.
GYNECOLOGIC ONCOLOGY (2006)
Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology
SMA Kulmala et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus
Denise J. Jamieson et al.
OBSTETRICS AND GYNECOLOGY (2006)
Distinct role of macrophages in different tumor microenvironments
CE Lewis et al.
CANCER RESEARCH (2006)
HPV-mediated cervical carcinogenesis: concepts and clinical implications
PJF Snijders et al.
JOURNAL OF PATHOLOGY (2006)
Spontaneous regression of high-grade cervical dysplasia: Effects of human papillomavirus type and HLA phenotype
CL Trimble et al.
CLINICAL CANCER RESEARCH (2005)
The epidemiology of human papillomavirus infections
JG Baseman et al.
JOURNAL OF CLINICAL VIROLOGY (2005)
Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX™ adjuvant in women with cervical intraepithelial neoplasia
IH Frazer et al.
VACCINE (2004)
Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: A randomized clinical trial
CJA Hogewoning et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Human papillomavirus virus-like particles do not activate langerhans cells: A possible immune escape mechanism used by human papillomaviruses
SC Fausch et al.
JOURNAL OF IMMUNOLOGY (2002)
Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo
SJ Um et al.
CANCER LETTERS (2002)
The causal relation between human papillomavirus and cervical cancer
FX Bosch et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Role of parity and human papillomavirus in cervical cancer:: the IARC multicentric case-control study
N Muñoz et al.
LANCET (2002)
Share Paper
